mAbs have been identified in animals to protect against some bunyavirus infections, such as anti-GP38 in CCHFV [233], anti-glycoprotein in LASV [264], and anti-glycoprotein JUNV [276]. This evidence concerns the gene ART4 and Bunyaviridae infectious disease.